These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 8759177

  • 21. Pituitary gonadotrophin secretion during the first weeks of pregnancy.
    Jeppsson S, Rannevik G, Thorell JI.
    Acta Endocrinol (Copenh); 1977 May; 85(1):177-88. PubMed ID: 324219
    [Abstract] [Full Text] [Related]

  • 22. The antigonadotropic activity of progestins (19-nortestosterone and 19-norprogesterone derivatives) is not mediated through the androgen receptor.
    Couzinet B, Young J, Brailly S, Chanson P, Thomas JL, Schaison G.
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4218-23. PubMed ID: 8954018
    [Abstract] [Full Text] [Related]

  • 23. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density.
    Rannevik G, Jeppsson S, Johnell O, Bjerre B, Laurell-Borulf Y, Svanberg L.
    Maturitas; 1995 Feb; 21(2):103-13. PubMed ID: 7752947
    [Abstract] [Full Text] [Related]

  • 24. Age related changes in follicle stimulating hormone, luteinizing hormone, oestradiol and immunoreactive inhibin in women of reproductive age.
    MacNaughton J, Banah M, McCloud P, Hee J, Burger H.
    Clin Endocrinol (Oxf); 1992 Apr; 36(4):339-45. PubMed ID: 1424166
    [Abstract] [Full Text] [Related]

  • 25. Serum inhibin levels during the periovulatory interval in normal women: relationships with sex steroid and gonadotrophin levels.
    McLachlan RI, Cohen NL, Dahl KD, Bremner WJ, Soules MR.
    Clin Endocrinol (Oxf); 1990 Jan; 32(1):39-48. PubMed ID: 2110047
    [Abstract] [Full Text] [Related]

  • 26. Androgenic progestogens oppose the decrease of insulin-like growth factor I serum level induced by conjugated oestrogens in postmenopausal women. Preliminary report.
    Campagnoli C, Biglia N, Lanza MG, Lesca L, Peris C, Sismondi P.
    Maturitas; 1994 May; 19(1):25-31. PubMed ID: 7935029
    [Abstract] [Full Text] [Related]

  • 27. Do combinations of 1 mg estradiol and low doses of NETA effectively control menopausal symptoms?
    Baerug U, Winge T, Nordland G, Faber-Swensson E, Heldaas K, Norling B, Larsen S, Arce JC.
    Climacteric; 1998 Sep; 1(3):219-28. PubMed ID: 11907946
    [Abstract] [Full Text] [Related]

  • 28. Peritoneal fluid volume and levels of steroid hormones and gonadotrophins in peritoneal fluid of normal and norethisterone-treated women.
    Kim-Björklund T, Landgren BM, Hamberger L.
    Hum Reprod; 1991 Oct; 6(9):1233-7. PubMed ID: 1752923
    [Abstract] [Full Text] [Related]

  • 29. More basic isoforms of serum gonadotropins during gonadotropin-releasing hormone agonist therapy in pubertal children.
    Wide L, Albertsson-Wikland K, Phillips DJ.
    J Clin Endocrinol Metab; 1996 Jan; 81(1):216-21. PubMed ID: 8550754
    [Abstract] [Full Text] [Related]

  • 30. Effects of oral continuous 17beta-estradiol plus norethisterone acetate replacement therapy on abdominal subcutaneous fat, serum leptin levels and body composition.
    Yüksel H, Odabaşi AR, Demircan S, Karul A, Kozaci LD, Köseoğlu K, Kizilkaya K, Başak O.
    Gynecol Endocrinol; 2006 Jul; 22(7):381-7. PubMed ID: 16864148
    [Abstract] [Full Text] [Related]

  • 31. Endocrine and clinical effects of estradiol and testosterone pellets used in long-term replacement therapy.
    Kapetanakis E, Dmowski WP, Auletta F, Scommegna A.
    Int J Gynaecol Obstet; 1982 Oct; 20(5):387-99. PubMed ID: 6128271
    [Abstract] [Full Text] [Related]

  • 32. Serum placental protein 14 in pre-menopausal and post-menopausal women--dependency on oestrogen/progestogen status.
    Byrjalsen I, Riis BJ, Christiansen C.
    Maturitas; 1990 Jun; 12(2):79-88. PubMed ID: 2255265
    [Abstract] [Full Text] [Related]

  • 33. Serum estradiol and gonadotropins level in postmenopausal women with or without hormone replacement.
    Limpaphayom K, Taechakraichana N, Kittinunvorakoon C.
    J Med Assoc Thai; 1997 Mar; 80(3):147-52. PubMed ID: 9175381
    [Abstract] [Full Text] [Related]

  • 34. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
    Christodoulakos G, Lambrinoudaki I, Panoulis C, Sioulas V, Rizos D, Caramalis G, Botsis D, Creatsas G.
    Maturitas; 2005 Apr 11; 50(4):321-30. PubMed ID: 15780533
    [Abstract] [Full Text] [Related]

  • 35. Laboratory criteria for menopause in women using oral contraceptives.
    Creinin MD.
    Fertil Steril; 1996 Jul 11; 66(1):101-4. PubMed ID: 8752618
    [Abstract] [Full Text] [Related]

  • 36. Inappropriately low levels of gonadotrophins in amenorrhoeic women with alcoholic and non-alcoholic cirrhosis.
    Bell H, Raknerud N, Falch JA, Haug E.
    Eur J Endocrinol; 1995 Apr 11; 132(4):444-9. PubMed ID: 7711882
    [Abstract] [Full Text] [Related]

  • 37. The effect of short-term treatment with micronized estradiol on bone turnover and gonadotrophins in older men.
    Taxel P, Kennedy D, Fall P, Willard A, Shoukri K, Clive J, Raisz LG.
    Endocr Res; 2000 Aug 11; 26(3):381-98. PubMed ID: 11019903
    [Abstract] [Full Text] [Related]

  • 38. Transdermal 17 beta-estradiol combined with oral progestogen increases plasma levels of insulin-like growth factor-I in postmenopausal women.
    Slowinska-Srzednicka J, Zgliczynski S, Jeske W, Stopinska-Gluszak U, Srzednicki M, Brzezinska A, Zgliczynski W, Sadowski Z.
    J Endocrinol Invest; 1992 Aug 11; 15(7):533-8. PubMed ID: 1280287
    [Abstract] [Full Text] [Related]

  • 39. Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone binding globulin and free testosterone levels--an association with mammographic density.
    Hofling M, Carlström K, Svane G, Azavedo E, Kloosterboer H, Von Schoultz B.
    Gynecol Endocrinol; 2005 Feb 11; 20(2):110-5. PubMed ID: 15823831
    [Abstract] [Full Text] [Related]

  • 40. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B, Guzic-Salobir B, Sebestjen M, Keber I.
    Menopause; 2006 Feb 11; 13(4):643-50. PubMed ID: 16837886
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.